Karen Bergman
About Karen Bergman
Karen Bergman serves as the Vice President of Communications and Investor Relations at Bolt Biotherapeutics, Inc. She has extensive experience in guiding companies through various stages of growth, particularly in the life sciences and technology sectors.
Work at Bolt Biotherapeutics
Karen Bergman currently serves as Vice President of Communications and Investor Relations at Bolt Biotherapeutics, Inc. since 2021. In this role, she focuses on enhancing the company's communications strategy and investor relations efforts. Her responsibilities include developing narratives that drive corporate recognition and reputation. She leverages her extensive experience in the life sciences sector to advance Bolt Biotherapeutics' business opportunities.
Previous Experience in Corporate Communications
Prior to her current role, Karen Bergman held several significant positions in corporate communications and investor relations. She worked at FibroGen, Inc. as Vice President of Investor Relations & Corporate Communications from 2016 to 2019. Before that, she served as Vice President of Corporate Communications and Investor Relations at ALZA Corporation from 1997 to 2001, where she contributed to the company's transition during its acquisition by Johnson & Johnson.
Education and Expertise
Karen Bergman holds a Bachelor of Arts degree from Yale University, where she graduated cum laude with honors and distinction in her major. Additionally, she obtained a Graduate Certificate in Investor Relations from the University of Michigan's Stephen M. Ross School of Business. Her educational background supports her expertise in guiding companies through various stages of growth, particularly in the life sciences and biopharma sectors.
Strategic Consulting and Advisory Roles
In addition to her corporate roles, Karen Bergman has served as a strategic consultant and advisor. She was a Business Advisory Board Member at the Epilepsy Foundation from 2012 to 2016. In this capacity, she provided strategic guidance and insights to enhance the foundation's initiatives. Her experience as a C-suite advisor allows her to focus on both immediate and long-term objectives for organizations.
Background in Life Sciences and Technology
Karen Bergman has a robust background in the life sciences, biopharma, specialty pharma, and technology sectors. She has a proven track record of advancing business opportunities and building corporate brands. Her experience includes leveraging competitive intelligence to attract and retain investors, employees, and partners, which has been instrumental in her roles across various organizations.